|
C20ORF20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.71299999529984E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.03739999996111E-06 |
| Normal-vs-Stage2 |
9.589900E-02 |
| Normal-vs-Stage3 |
7.033400E-04 |
| Normal-vs-Stage4 |
1.436260E-02 |
| Stage1-vs-Stage2 |
2.965800E-02 |
| Stage1-vs-Stage3 |
1.292750E-01 |
| Stage1-vs-Stage4 |
9.258300E-02 |
| Stage2-vs-Stage3 |
1.107570E-02 |
| Stage2-vs-Stage4 |
4.724400E-02 |
| Stage3-vs-Stage4 |
7.905200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.162000001249E-08 |
| Normal-vs-AfricanAmerican |
2.922000E-03 |
| Normal-vs-Asian |
5.355900E-03 |
| Caucasian-vs-AfricanAmerican |
1.218350E-02 |
| Caucasian-vs-Asian |
9.631000E-01 |
| AfricanAmerican-vs-Asian |
3.016600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.4093000000901E-07 |
| Normal-vs-Female |
2.87980000002186E-06 |
| Male-vs-Female |
4.100600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.154700E-04 |
| Normal-vs-Extreme_Weight |
4.2190000000053E-05 |
| Normal-vs-Obese |
1.70396999999989E-05 |
| Normal-vs-Extreme_Obese |
1.718180E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.811600E-01 |
| Normal_Weight-vs-Obese |
8.343400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.936100E-02 |
| Extreme_Weight-vs-Obese |
4.765400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.558300E-02 |
| Obese-vs-Extreme_Obese |
2.648400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.625600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.08269999527155E-08 |
| Normal-vs-Age(61-80Yrs) |
3.97709999999663E-05 |
| Normal-vs-Age(81-100Yrs) |
9.484800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.251600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.320400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.756500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.459600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.510160E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.368100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.52840004278232E-09 |
| Normal-VS-Type2 PRCC |
1.026610E-01 |
| Normal-VS-KIRP CIMP |
1.80930000004409E-06 |
| Normal-VS-Unclassified PRCC |
5.817300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.155100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.151800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.400200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.562600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.930000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.611600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.954300E-02 |
| Normal-vs-N1 |
1.229330E-04 |
| Normal-vs-N2 |
2.415500E-03 |
| N0-vs-N1 |
3.603100E-03 |
| N0-vs-N2 |
1.928570E-01 |
| N1-vs-N2 |
6.164800E-01 |
|
|
